StacksVerified U.S. regulatory reference

21 CFR §524.981c

Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov
  1. (a)Specifications. The drug contains 0.025 percent fluocinolone acetonide and 0.5 percent neomycin sulfate (0.35 percent neomycin base).
  2. (b)Sponsor. See No. 099207 in § 510.600(c) of this chapter.
  3. (c)Conditions of use in dogs—(1) Amount. A small amount is applied to the affected area two or three times daily.
    1. (2)Indications for use—(i) Dogs. For the relief of pruritis and inflammation associated with superficial acute and chronic dermatoses. It is used in the treatment of allergic and acute moist dermatitis and nonspecific dermatoses.
      1. (ii)Dogs and cats. Used in the treatment of wound infections.
    2. (3)Federal law restricts this drug to use by or on the order of a licensed veterinarian.